| Methods |
Allocation concealment: NA
Blinding of study: no
Support: none declared |
| Participants |
186 participants total
Excluded: none
Bone marrow transplantation, prophylactic |
| Interventions |
Fluconazole: 200 mg/d orally
Amphotericin B: 0.2 mg/kg/d iv, maximum dose 10 mg |
| Outcomes |
Death
Infections
Use of escape drug
Dropouts because of adverse effects |
| Notes |
Follow‐up period (days): 100
Days on fluconazole 20. Days on amphotericin B: 20
Support: none declared |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
| Blinding (performance bias and detection bias)
All outcomes |
High risk |
|
